Laura Jamieson
About Laura Jamieson
Laura Jamieson serves as the Head of Global Commercial Training & Development at Amylyx Pharmaceuticals, bringing extensive experience in training and development within the biotech and pharmaceutical sectors. Her background includes roles at AMAG Pharmaceuticals, Foundation Medicine, and EMD Serono, where she developed skills in stakeholder engagement, launch meeting planning, and biomarker testing.
Current Role at Amylyx Pharmaceuticals
Laura Jamieson serves as the Head Global Commercial Training & Development at Amylyx Pharmaceuticals since 2021. In this role, she oversees the development and implementation of training programs that support the company's commercial objectives. Her responsibilities include ensuring that training initiatives align with both US and international market needs, leveraging her global training experience.
Previous Experience at AMAG Pharmaceuticals
Before joining Amylyx Pharmaceuticals, Laura Jamieson worked at AMAG Pharmaceuticals as the Manager of Sales Training from 2014 to 2015. In this position, she focused on enhancing the sales team's capabilities through targeted training initiatives, contributing to the overall effectiveness of the sales force.
Experience at Foundation Medicine
Laura held the position of Associate Director of Commercial Training & Development at Foundation Medicine from 2016 to 2017. Based in Cambridge, Massachusetts, she was responsible for developing training programs that supported the company's commercial strategies, particularly in the field of oncology.
Career at EMD Serono, Inc.
At EMD Serono, Inc., Laura Jamieson served in multiple roles. She was the Associate Director of Commercial Learning & Development - Oncology from 2017 to 2020, followed by her role as Director, Field Force Effectiveness - Oncology from 2020 to 2021. In these positions, she focused on training and development for oncology sales teams, enhancing their effectiveness and engagement with stakeholders.
Educational Background
Laura Jamieson earned her Bachelor of Science in Nursing (BSN) from Widener University. This educational background provides her with a solid foundation in healthcare, which complements her extensive experience in the pharmaceutical and biotech industries.